CAMKK2, Regulated by Promoter Methylation, Is a Prognostic Marker in Diffuse Gliomas

CNS Neuroscience and Therapeutics - United Kingdom
doi 10.1111/cns.12531
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy